Anyone buy the pullback? Oh yeah!!!
I added, and glad I did.
I am buying it. Second class citizen, compared to ACRX, RMTI, SNTS. If ZLCS has good results it will moon walk though.
I think this latest data on the other drug in Phase 1 gives a lot of support to take a chance on the phase 2 candidate. It is no longer all or nothing.